The role of the breast cancer susceptibility gene 1 (BRCA1) in sporadic epithelial ovarian cancer

Reproductive Biology and Endocrinology

Volumn 1, Issue , 2003, Pages

  McCoy, Marcia L ^a   Mueller, Christopher R ^b   Roskelley, Calvin D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CYCLIC AMP; DNA BINDING PROTEIN; TRANSCRIPTION FACTOR; TUMOR PROTEIN;

ALLELE; CANCER THERAPY; CARCINOGENESIS; CORRELATION FUNCTION; DISEASE COURSE; DOWN REGULATION; EPIGENETICS; EPITHELIUM; FAMILIAL CANCER; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE LOCUS; GENE LOSS; GENE MUTATION; HUMAN; OVARY CANCER; OVARY CARCINOMA; PREVALENCE; PROMOTER REGION; PROTEIN METHYLATION; REVIEW; SOMATIC MUTATION; TRANSCRIPTION REGULATION; TUMOR GROWTH; TUMOR SUPPRESSOR GENE; ANIMAL; CARCINOMA; DNA METHYLATION; GENETIC EPIGENESIS; GENETIC TRANSCRIPTION; GENETICS; MOUSE; MOUSE MUTANT; OVARY TUMOR; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; BRCA1 PROTEIN; CARCINOMA; DNA METHYLATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, BRCA1; HUMANS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PREVALENCE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 4344665689     PISSN: 14777827     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7827-1-72     Document Type: Review

References (55)

1. Parkin DM, Pisani P, Ferlay J: Global cancer statistics. CA Cancer J Clin 1999, 49:33-64.
2. Scully RE: Pathology of ovarian cancer precursors. J Cell Biochem 1995, 23(s):208-218.
3. Feeley KM, Wells M: Precursor lesions of ovarian epithelial malignancy. Histopathology 2001, 38:87-95.
4. Orsulic S, Li Y, Soslow RA, Vitale-Cross LA, Gutkind JS, Varmus HE: Induction of ovarian cancer by defined multiple genetic changes in a mouse model system. Cancer Cell 2002, 1:53-62.
5. Connolly DC, Bao R, Nikitin AY, Stephens KC, Poole TW, Hua X, Harris SS, Vanderhyden BC, Hamilton TC: Female mice chimeric for expression of the simian virus 40 TAg under control of the MISIIR promoter develop epithelial ovarian cancer. Cancer Res 2003, 63:1389-1397.
6. Aunoble B, Sanches R, Didier E, Bignon YJ: Major oncogenes and tumor suppressor genes involved in epithelial ovarian cancer. Int J Oncol 2000, 16:567-576.
7. Wenham RM, Lancaster JM, Berchuck A: Molecular aspects of ovarian cancer. Best Pract Res Clin Obstet Gynaecol 2002, 16:483-497.
8. Hough CD, Sherman-Baust CA, Pizer ES, Montz FJ, Im DD, Rosenshein NB, Cho KR, Riggins GJ, Morin PJ: Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer. Cancer Res 2000, 60:6281-6287.
9. Hough CD, Cho KR, Zonderman AB, Schwartz DR, Morin PJ: Coordinately up-regulated genes in ovarian cancer. Cancer Res 2001, 61:3869-3876.
10. Sawiris GP, Sherman-Baust CA, Becker KG, Cheadle C, Teichberg D, Morin PJ: Development of a highly specialized cDNA array for the study and diagnosis of epithelial ovarian cancer. Cancer Res 2002, 62:2923-2928.
11. Kerr P, Ashworth A: New complexities for BRCA1 and BRCA2. Curr Biol 2001, 11:R668-676.
12. Venkitaraman AR: Cancer susceptibility and the functions of BRCA1 and BRCA2. Cell 2002, 108:171-182.
13. Hakem R, de la Pompa JL, Sirard C, Mo R, Woo M, Hakem A, Wakeham A, Potter J, Reitmair A, Billia F, Firpo E, Hui CC, Roberts J, Rossant J, Mak TW: The tumor suppressor gene Brca1 is required for embryonic cellular proliferation in the mouse. Cell 1996, 85:1009-1023.
14. Hakem R, de la Pompa JL, Elia A, Potter J, Mak TW: Partial rescue of BRCA1 early embryonic lethality by p53 or p21 null mutation. Nat Genet 1997, 16:298-302.
15. Xu X, Wagner KU, Larson D, Weaver Z, Li C, Ried T, Hennighausen L, Wynshaw-Boris A, Deng CX: Conditional mutation of BRCA1 in mammary epithelial cells results in blunted ductal morphogenesis and tumor formation. Nat Genet 1999, 22:37-43.
16. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, et al: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266:66-71.
17. Easton DF, Ford D, Bishop DT: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Am J Hum Genet 1995, 56:265-271.
18. Smith SA, Easton DF, Evans DG, Ponder BA: Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome. Nat Genet 1992, 2:128-131.
19. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett LM, Haugen-Strano A, Swensen J, Miki Y, et al: BRCA1 mutations in primary breast and ovarian carcinomas. Science 1994, 266:120-122.
20. Berchuck A, Heron KA, Carney ME, Lancaster JM, Fraser EG, Vinson VL, Deffenbaugh AM, Miron A, Marks JR, Futreal PA, Frank TS: Frequency of germline and somatic BRCA1 mutations in ovarian cancer. Clin Cancer Res 1998, 4:2433-2437.
21. Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Kwan E, Jack E, Vesprini DJ, Kuperstein G, Abrahamson JL, Fan I, Wong B, Narod SA: Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001, 68:700-710.
22. Cass I, Baldwin RL, Varkey T, Moslehi R, Narod SA, Karlan BY: Improved survival in women with BRCA-associated ovarian carcinoma. Cancer 2003, 97:2187-2195.
23. Hosking L, Trowsdale J, Nicolai H, Solomon E, Foulkes W, Stamp G, Signer E, Jeffreys A: A somatic BRCA1 mutation in an ovarian tumor. Nat Genet 1995, 9:343-344.
24. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C, Frank TS: Somatic mutations in the BRCA1 gene in sporadic ovarian tumors. Nat Genet 1995, 9:439-443.
25. Takahashi H, Behbakht K, McGovern PE, Chiu HC, Couch FJ, Weber BL, Friedman LS, King MC, Furusato M, LiVolsi VA, et al: Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res 1995, 55:2998-3002.
26. Khoo US, Ozcelik H, Cheung AN, Chow LW, Ngan HY, Done SJ, Liang AC, Chan VW, Au GK, Ng WF, Poon CS, Leung YF, Loong F, Ip P, Chan GS, Andrulis IL, Lu J, Ho FC: Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer. Oncogene 1999, 18:4643-4646.
27. Mueller CR, Roskelley CD: Regulation of BRCA1 expression and its relationship to sporadic breast cancer. Breast Cancer Res 2002, 5:45-52.
28. Thompson ME, Jensen RA, Obermiller PS, Page DL, Holt JT: Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression. Nat Genet 1995, 9:444-450.
29. Taylor J, Lymboura M, Pace PE, A'hern RP, Desai AJ, Shousha S, Coombes RC, Ali S: An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers. Int J Cancer 1998, 79:334-342.
30. Yoshikawa K, Honda K, Inamoto T, Shinohara H, Yamauchi A, Suga K, Okuyama T, Shimada T, Kodama H, Noguchi S, Gazdar AF, Yamaoka Y, Takahashi R: Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases. Clin Cancer Res 1999, 5:1249-1261.
31. Seery LT, Knowlden JM, Gee JM, Robertson JF, Kenny FS, Ellis IO, Nicholson RI: BRCA1 expression levels predict distant metastasis of sporadic breast cancers. Int J Cancer 1999, 84:258-262.
32. Wilson CA, Ramos L, Villasenor MR, Anders KH, Press MF, Clarke K, Karlan B, Chen JJ, Scully R, Livingston D, Zuch RH, Kanter MH, Cohen S, Calzone FJ, Slamon DJ: Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas. Nat Genet 1999, 21:236-240.
33. Zheng W, Luo F, Lu JJ, Baltayan A, Press MF, Zhang ZF, Pike MC: Reduction of BRCA1 expression in sporadic ovarian cancer. Gynecol Oncol 2000, 76:294-300.
34. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E, Bussaglia E, Prat J, Harkes IC, Repasky EA, Gabrielson E, Schutte M, Baylin SB, Herman JG: Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 2000, 92:564-569.
35. Russell PA, Pharoah PD, De Foy K, Ramus SJ, Symmonds I, Wilson A, Scott I, Ponder BA, Gayther SA: Frequent loss of BRCA1 mRNA and protein expression in sporadic ovarian cancers. Int J Cancer 2000, 87:317-321.
36. Bird AP: CpG-rich islands and the function of DNA methylation. Nature 1986, 321:209-213.
37. Kass SU, Pruss D, Wolffe AP: How does DNA methylation repress transcription? Trends Genet 1997, 13:444-449.
38. Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A: Tumor-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 2000, 21:147-51.
39. Catteau A, Morris JR: BRCA1 methylation: a significant role in tumor development? Semin Cancer Biol 2002, 12:359-371.
40. Chan KY, Ozcelik H, Cheung AN, Ngan HY, Khoo US: Epigenetic factors controlling the BRCA1 and BRCA2 genes in sporadic ovarian cancer. Cancer Res 2002, 62:4151-4156.
41. Baylin SB: Mechanisms underlying epigenetically mediated gene silencing in cancer. Semin Cancer Biol 2002, 12:331-337.
42. Catteau A, Harris WH, Xu CF, Solomon E: Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 1999, 18:1957-1965.
43. Baldwin RL, Nemeth E, Tran H, Shvartsman H, Cass I, Narod S, Karlan BY: BRCA1 promoter region hypermethylation in ovarian carcinoma: a population-based study. Cancer Res 2000, 60:5329-5333.
44. Xu CF, Chambers JA, Solomon E: Complex regulation of the BRCA1 gene. J Biol Chem 1997, 272:20994-20997.
45. Suen TC, Goss PE: Identification of a novel transcriptional repressor element located in the first intron of the human BRCA1 gene. Oncogene 2001, 20:440-450.
46. Thakur S, Nakamura T, Calin G, Russo A, Tamburrino JF, Shimizu M, Baldassarre G, Battista S, Fusco A, Wassell RP, Dubois G, Alder H, Croce CM: Regulation of BRCA1 Transcription by Specific Single-Stranded DNA Binding Factors. Mol Cell Biol 2003, 23:3774-3787.
47. Atlas E, Stramwasser M, Mueller CR: A CREB site in the BRCA1 proximal promoter acts as a constitutive transcriptional element. Oncogene 2001, 20:7110-7114.
48. Mancini DN, Rodenhiser DI, Ainsworth PJ, O'Malley FP, Singh SM, Xing W, Archer TK: CpG methylation within the 5′ regulatory region of the BRCA1 gene is tumor specific and includes a putative CREB binding site. Oncogene 1998, 16:1161-1169.
49. DiNardo DN, Butcher DT, Robinson DP, Archer TK, Rodenhiser DI: Functional analysis of CpG methylation in the BRCA1 promoter region. Oncogene 2001, 20:5331-5340.
50. McCoy ML, Wu C, Mueller CR, Roskelley CD: Differential regulation of the BRCA1 promoter in normal ovarian surface epithelia and ovarian carcinoma cells [abstract]. Proc American Ass'n Cancer Res 2003, 44:4850a.
51. Sharrocks AD: The ETS-domain transcription factor family. Nat Rev Mol Cell Biol 2001, 2:827-837.
52. Atlas E, Stramwasser M, Whiskin K, Mueller CR: GA-binding protein alpha/beta is a critical regulator of the BRCA1 promoter. Oncogene 2000, 19:1933-1940.
53. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P, Welch PJ, Welte K, King MC, Barber JR, Wong-Staal F: Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci USA 2001, 98:130-135.
54. Coppe JP, Smith AP, Desprez PY: Id proteins in epithelial cells. Exp Cell Res 2003, 285:131-45.
55. Baker KM, Wei G, Schaffner AE, Ostrowski MC: Ets-2 and Components of Mammalian SWI/SNF Form a Repressor Complex That Negatively Regulates the BRCA1 Promoter. J Biol Chem 2003, 278:17876-17884.